- E-mailkristian.jansen@uib.no
- Visitor AddressAlrek helseklynge, blokk D, Årstadveien 175009 Bergen
- Postal AddressPostboks 78045020 Bergen
- (2022). Gode pasientforløp.
- (2021). Evaluating an integrated care pathway for frail elderly patients in Norway using multi-criteria decision analysis. BMC Health Services Research.
- (2020). Utbrudd av covid-19 ved tre sykehjem i Bergen. Tidsskrift for Den norske legeforening. 1-9.
- (2017). Evidence base for palliative drug treatment in the last days of life - a systematic review.
- (2017). End of life care in nursing homes. Palliative drug prescribing and doctors’ existential vulnerability.
More information in national current research information system (CRIStin)
End-of-life in the nursing home
Nearly half of all deaths in Norway occur in nursing homes. What is the doctor’s role in patient care at the end-of-life in nursing homes? Our project focuses three aspects:
Challenges experienced by doctors working with dying nursing home patients
Drug prescribing near the end of life
Evidence base for palliative drug treatment
Doctors challenges
Based on focus group interviews, we explore nursing home doctors' experiences with dying patients in nursing homes. Such knowledge can help increase doctors' focus on preparatory conversations and interdisciplinary cooperation at the end of life.
Palliative medication
A cohort study among deceased nursing home patients showed that palliative medication was prescribed to 74% of patients on the day of death; especially for cancer patients and patients with long stays. Most drug changes occurred on the day of death.
Evidence-based drug treatment
We conduct a systematic review of research-based knowledge about medication at the end of life.
0 0 1 163 930 Løvåsen Sykehjem 7 2 1091 14.0 Normal 0 false false false NO-BOK JA X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:Cambria; mso-ascii-font-family:Cambria; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Cambria; mso-hansi-theme-font:minor-latin; mso-fareast-language:JA;}
Funding: General Practice Research Fund